Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Clinical Value and Safety of Xiyanping Injection in the Treatment of Community-acquired Pneumonia in Children Based on Real-world Clinical Data

NCT04158310 is registered in ClinicalTrials.gov with Jiangxi Qingfeng Pharmaceutical Co. Ltd. as lead sponsor.

NCT NCT04158310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04158310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Clinical Value and Safety of Xiyanping Injection in the Treatment of Community-acquired Pneumonia in Children Based on Real-world Clinical Data
Lead sponsor
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Phase
Observational
Overall status
Unknown status
Start date
November 11, 2019
Completion date
March 1, 2021
Enrollment
9,207 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

community acquired pneumonia